| 证券代码：603306 | 证券简称：华懋科技 | 公告编号：2025-097 | | --- | --- | --- | | 债券代码：113677 | 债券简称：华懋转债 | | 华懋（厦门）新材料科技股份有限公司 关于 2025 年第三季度可转债转股结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 转股情况：2025 年 7 月 1 日至 2025 年 9 月 30 日期间，共有 752,000 元"华 懋转债"已转换成公司股份，本期因转股形成的股份数量为 22,265 股。截至 2025 年 9 月 30 日，累计已有 790,000 元"华懋转债"转换成公司股份，累计回售 1,000 元"华懋转债"，累计因转股形成的股份数量为 23,373 股，占可转债转股前公 司已发行股份总额的 0.00717%。 未转股可转债情况：截至 2025 年 9 月 30 日，公司尚未转股的"华懋转债" 金额为 104,920.90 万元，占"华懋转债"发行总量的 99.92467%。 一、可转债发 ...

| 证券代码：603306 | 证券简称：华懋科技 | 公告编号：2025-096 | | --- | --- | --- | | 债券代码：113677 | 债券简称：华懋转债 | | 华懋（厦门）新材料科技股份有限公司 关于 2021 年股票期权激励计划 2025 年第三季度自主行权结 果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股票期权激励计划行权结果：2025 年 7 月 1 日至 2025 年 9 月 30 日，行 权数量为 406,320 股。截至 2025 年 9 月 30 日，华懋（厦门）新材料科技股 份有限公司（以下简称"公司"）2021 年股票期权激励计划（以下简称"本 次激励计划"）预留授予股票期权的第三个行权期内累计行权且完成过户登 记 1,083,540 股，本次激励计划预留授予股票期权第三个行权期已于 2025 年 9 月 5 日届满。截止本公告披露日，公司 2021 年股票期权激励计划三个行权 期均已届满，本次激励计划结束。 本次行权缴款资金为人民币 8,70 ...

| 证券代码：603306 | 证券简称：华懋科技 | 公告编号：2025-101 | | --- | --- | --- | | 债券代码：113677 | 债券简称：华懋转债 | | 华懋（厦门）新材料科技股份有限公司 关于"华懋转债"转股价格调整暨转股停复牌的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因华懋（厦门）新材料科技股份有限公司（以下简称"本公司"或"公司"） 部分股票期权行权增发新股，引发华懋转债转股价格调整,本公司的相关证券停复 牌情况如下： | 113677 | 华懋转债 | 可转债转股停 牌 | 2025/10/10 | 全天 | 2025/10/10 | 2025/10/13 | | --- | --- | --- | --- | --- | --- | --- | | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌 期间 | 停牌终止日 | 复牌日 | 调整前转股价格：33.76 元/股 调整后转股价格：33.74 元/股 华懋转债本 ...

| 证券代码：603306 | 证券简称：华懋科技 | 公告编号: 2025-100 | | --- | --- | --- | | 债券代码：113677 | 债券简称：华懋转债 | | 华懋（厦门）新材料科技股份有限公司 关于获得发明专利证书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证书号：第 8333273号 专利权自授权公告之日起生效。专利权有效性及专利权人变更等法律信息以 专利登记簿记载为准。 上述发明专利是公司重要核心技术的体现和延伸，本次专利获得不会对公司 目前经营产生重大影响，但有利于进一步完善公司知识产权保护体系，充分发挥 主导产品的知识产权优势，促进技术创新，从而提升公司核心竞争力。 发明名称：一种一次成型的安全气囊导气袋自动缝纫设备及其制造工艺 发明人：王向中；廖喜明；陈丽；刘怡；杨毅强 专利号：ZL 2023 1 0904827.4 专利类型：发明专利 专利申请日：2023年07月21日 专利权人：华懋（厦门）新材料科技股份有限公司 授权公告日：2025年10月03日 华懋（厦门）新材料科 ...

华懋（厦门）新材料科技股份有限公司 2025 年第三次临时股东会会议资料 证券简称：华懋科技 证券代码：603306 债券简称：华懋转债 债券代码：113677 华懋（厦门）新材料科技股份有限公司 2025 年第三次临时股东会 会议资料 2025 年 10 月 华懋（厦门）新材料科技股份有限公司 2025 年第三次临时股东会会议资料 目 录 | 年第三次临时股东会参会须知 2025 1 | | --- | | 2025 年第三次临时股东会会议议程 3 | | 议案一：关于公司发行股份及支付现金购买资产并募集配套资金暨关联交易符合 | | 相关法律、法规规定的议案 5 | | 议案二：关于华懋（厦门）新材料科技股份有限公司发行股份及支付现金购买资 | | 产并募集配套资金暨关联交易方案的议案 7 | | 议案三：关于《公司发行股份及支付现金购买资产并募集配套资金暨关联交易报 | | 告书（草案）》及其摘要的议案 19 | | 议案四：关于公司与交易对方签署附条件生效的《发行股份及支付现金购买资产 | | 补充协议》的议案 20 | | 议案五：关于公司与交易对方签署附条件生效的《有关募集配套资金之股份认购 | ...

Group 1 - The core point of the article is the announcement by Huamao Technology regarding the resignation of its board secretary, Xiao Jianbo, who will continue as the financial head, and the appointment of Zang Kun as the new board secretary [1] - For the fiscal year 2024, Huamao Technology's revenue composition is heavily weighted towards the automotive parts sector, accounting for 98.66% of total revenue, while other businesses contribute only 1.34% [1] - As of the report date, Huamao Technology has a market capitalization of 16.8 billion yuan [1]

Group 1 - Double-Helix Pharmaceutical announced that its associate, Changfeng Pharmaceutical, is expected to be listed on the Hong Kong Stock Exchange on October 8, 2025, with a global offering of 41.198 million shares priced at HKD 14.75 each. Double-Helix holds approximately 3.68% of Changfeng's shares, with a lock-up period of 12 months post-listing [1] - Changfeng Pharmaceutical is involved in the pharmaceutical industry, specifically in the research and development of gene-engineered drugs [2] Group 2 - Lio Corporation has submitted an application to the Hong Kong Stock Exchange for issuing H-shares and listing on the main board [3] - Lio Corporation operates in the mechanical manufacturing and digital marketing sectors [3] Group 3 - Changjiang Securities received approval from the China Securities Regulatory Commission to issue corporate bonds totaling no more than CNY 20 billion, valid for 24 months [4] - Changjiang Securities provides services such as securities and futures brokerage, financial product distribution, investment advisory, asset custody, and margin financing [4] Group 4 - Jingye Intelligent plans to acquire 51% of Hefei Shengwen Information Technology for CNY 108 million, focusing on engineering information technology and intelligent products [5][6] - Jingye Intelligent specializes in the research, development, production, and sales of special robots and intelligent equipment systems [6] Group 5 - Aimeike's subsidiary received approval for the registration of Minoxidil topical solution, a non-prescription drug for treating hair loss [7][8] - Aimeike is engaged in the research, development, production, and sales of biomedical materials and biopharmaceuticals [8] Group 6 - Dalian Heavy Industry expects a net profit of CNY 474 million to CNY 508 million for the first three quarters of 2025, representing a year-on-year increase of 19.91% to 28.52% [9] - Dalian Heavy Industry specializes in the design, manufacturing, assembly, and installation of major technical equipment [9] Group 7 - Huayou Cobalt signed supply agreements with LGES for a total of approximately 76,000 tons of ternary precursor products from 2026 to 2030 [10][11] - Huayou Cobalt focuses on the research, manufacturing, and sales of new energy lithium battery materials and cobalt new materials [11] Group 8 - Zhenjiang Co. plans to reduce its shareholding by up to 5.529 million shares, not exceeding 3% of the total share capital, due to personal funding needs [12] - Zhenjiang Co. is involved in the design, processing, and sales of wind power equipment and components [12] Group 9 - Watson Bio's subsidiary received a drug registration certificate for a 13-valent pneumococcal polysaccharide conjugate vaccine for children [14][15] - Watson Bio specializes in the research, development, production, and sales of human vaccines and biopharmaceuticals [15] Group 10 - Yikang Pharmaceutical's major shareholder plans to reduce holdings by up to 42 million shares, not exceeding 2.04% of the total share capital, due to personal funding needs [16] - Yikang Pharmaceutical is engaged in the production and sales of excipients, raw materials, finished drugs, and new energy materials [16] Group 11 - Sichuan Gold's shareholder plans to reduce holdings by up to 7.56 million shares, accounting for 1.80% of the total share capital [19] - Sichuan Gold focuses on the construction, mining, and sales of gold mines [19] Group 12 - Kangchen Pharmaceutical received approval for a clinical trial of an innovative drug for treating advanced esophageal squamous cell carcinoma [20][21] - Kangchen Pharmaceutical specializes in the manufacturing of chemical drug formulations [21] Group 13 - UCloud plans to repurchase shares worth between CNY 8 million and CNY 10 million for employee stock ownership plans [22] - UCloud provides cloud computing services centered on IT infrastructure [22] Group 14 - Woton Technology announced an adjustment to its share repurchase plan, raising the price cap to CNY 60 per share [24] - Woton Technology specializes in the research, manufacturing, and sales of separation membrane products [24] Group 15 - Five Continents Medical announced plans for shareholders to reduce holdings by up to 126,530 shares, accounting for 1.8606% of the total share capital [26] - Five Continents Medical focuses on the research, manufacturing, and sales of disposable sterile infusion medical devices [26] Group 16 - CIMC Group plans to repurchase A-shares with a total amount not exceeding CNY 5 billion [27] - CIMC Group specializes in logistics and energy equipment solutions [27] Group 17 - Zhifei Biological's subsidiary received a drug registration certificate for a trivalent influenza vaccine suitable for individuals aged 3 and above [29][30] - Zhifei Biological is involved in the research, development, production, and sales of vaccines and biological products [30]

Market Overview - The automotive parts sector experienced a slight decline of 0.14% on September 30, with ST Meichen leading the drop [1] - The Shanghai Composite Index closed at 3882.78, up 0.52%, while the Shenzhen Component Index closed at 13526.51, up 0.35% [1] Stock Performance - Notable gainers in the automotive parts sector included: - N Ruili (Code: 001285) with a closing price of 63.39, up 49.93% and a trading volume of 273,800 shares, totaling 1.888 billion yuan [1] - Songyuan Safety (Code: 300893) with a closing price of 39.90, up 20.00% and a trading volume of 174,400 shares, totaling 636 million yuan [1] - Shanzi Gaoke (Code: 000981) with a closing price of 4.24, up 10.13% and a trading volume of 15.0676 million shares, totaling 6.293 billion yuan [1] Fund Flow Analysis - The automotive parts sector saw a net outflow of 640 million yuan from major funds, while retail investors contributed a net inflow of 274 million yuan [2] - Major funds showed significant inflows in stocks like Shanzi Gaoke and N Ruili, while experiencing outflows in stocks like Zongtai Automobile [3] Individual Stock Insights - N Ruili had a major net inflow from retail investors of 494 million yuan, while it faced a net outflow of 948 million yuan from major funds [3] - Shanzi Gaoke experienced a net inflow of 838 million yuan from major funds, but had a net outflow of 431 million yuan from retail investors [3]

Core Viewpoint - Huamao Technology plans to acquire the remaining 57.84% stake in Fuchuang Youyue Technology, making it a wholly-owned subsidiary, through a significant asset restructuring transaction valued at 1.504 billion yuan [1][2]. Group 1: Transaction Details - The total transaction price for acquiring the 57.84% stake in Fuchuang Youyue is 1.504 billion yuan, with 1.022 billion yuan (68.00%) paid through the issuance of shares at a price of 29.80 yuan per share, and 481 million yuan (32.00%) paid in cash [1]. - Huamao Technology plans to raise up to 951 million yuan by issuing shares to its controlling shareholder, Dongyang Huasheng, primarily to fund cash payments and various projects including a new production base in Malaysia and expansion of the Shenzhen factory [1]. Group 2: Company and Industry Insights - Fuchuang Youyue is positioned in the global AI and computing power manufacturing industry, focusing on high-reliability complex products such as high-speed optical modules and copper cable connectors, with established partnerships with three of the top ten global optical module manufacturers [2]. - Financial data indicates strong growth for Fuchuang Youyue, with projected revenues of 643 million yuan and net profits of 75 million yuan for the first four months of 2025, and total assets reaching 1.782 billion yuan, a 43.50% increase compared to the end of 2024 [2]. - The transaction includes profit commitments from the sellers, ensuring net profits of no less than 200 million yuan, 250 million yuan, and 330 million yuan for the years 2025, 2026, and 2027 respectively, totaling a minimum of 780 million yuan [2]. - The acquisition allows Huamao Technology to enter the rapidly growing optical communication sector, with the raised funds expected to enhance production capacity to meet increasing market demand [2].

Core Viewpoint - Huamao Technology announced a major asset restructuring plan to acquire the remaining 57.84% equity of Shenzhen Fuchuang Excellent Technology Co., Ltd. for a total consideration of 1.504 billion yuan, which will make Fuchuang Excellent a wholly-owned subsidiary of Huamao Technology [1][2] Group 1: Transaction Details - The transaction price will be paid 68% in Huamao Technology's shares and 32% in cash, with the issuance of 34.3157 million shares at a price of 29.8 yuan per share [2] - Huamao Technology plans to raise up to 951 million yuan from its controlling shareholder to fund the cash payment and support the construction of Fuchuang Excellent's new production base in Malaysia, expansion of its Shenzhen factory, and upgrade of its R&D center [2] - The counterpart in the transaction has committed to performance targets for Fuchuang Excellent, with net profits of no less than 200 million yuan, 250 million yuan, and 330 million yuan for the years 2025, 2026, and 2027, respectively, totaling a minimum of 780 million yuan [2] Group 2: Company Profile - Fuchuang Excellent is a global player in the AI and computing power manufacturing industry, focusing on the intelligent manufacturing of core components such as high-speed optical modules and high-speed copper cable connectors [3] - The company has established stable partnerships with three of the top ten global optical module manufacturers and several domestic and international high-speed copper cable connector enterprises [3] Group 3: Financial Performance - Fuchuang Excellent achieved revenues of 570 million yuan, 1.231 billion yuan, and 643 million yuan for the years 2023, 2024, and the first four months of 2025, respectively, with net profits of 24.17 million yuan, 129 million yuan, and 74.93 million yuan [4] - In the first four months of 2025, the revenue breakdown by product shows that optical communication products accounted for 73.17%, copper cable connectors for 17.26%, and maritime communication products for 5.49%, with corresponding gross margins of 22.42%, 10.87%, and 11.56% [4] - The revenue distribution by region in the first four months of 2025 indicates that domestic sales were 233 million yuan (37.47%) and international sales were 388 million yuan (62.53%) [4] - Fuchuang Excellent faces a high customer concentration risk, with sales to its top five customers accounting for 87.48%, 88.98%, and 85.40% of total revenue in 2023, 2024, and the first four months of 2025, respectively [4]